SCHEMBL19089403

SCHEMBL19089403

C=CC(=O)Nc1cc(Nc2cc(-c3cn(C(C)C)c4ccc(F)cc34)ncn2)c(OC)cc1N(C)CCN1CCCC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.60
ERBB3 P21860 2/20 0.48
MLNR O43193 1/20 0.47
KDM1A O60341 1/20 0.47
ABCB11 O95342 1/20 0.47
ERBB2 P04626 1/20 0.47
INSR P06213 1/20 0.47
CHRM2 P08172 1/20 0.47
HTR1A P08908 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
DRD2 P14416 1/20 0.47
NQO2 P16083 1/20 0.47
ADRA2C P18825 1/20 0.47
DRD1 P21728 1/20 0.47
SLC6A2 P23975 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
ADORA2A P29274 1/20 0.47
SLC6A4 P31645 1/20 0.47
CCKAR P32238 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20548869 0.91 EGFR (0.69) EGFRERBB3MLNRKDM1AABCB11
SCHEMBL20548742 0.84 EGFR (0.83) EGFRERBB3MLNRKDM1AABCB11
SCHEMBL19089398 0.84 EGFR (0.83) EGFRERBB3MLNRKDM1AABCB11
SCHEMBL20548852 0.82 EGFR (0.83) EGFRERBB3MLNRKDM1AABCB11
SCHEMBL19089410 0.82 EGFR (0.67) EGFRERBB3
SCHEMBL19089322 0.81 EGFR (0.65) EGFRERBB3MLNRKDM1AABCB11
SCHEMBL19089397 0.80 EGFR (0.83) EGFRERBB3MLNRKDM1AABCB11
SCHEMBL20548933 0.79 EGFR (0.49) EGFRKCNH2
SCHEMBL20548865 0.79 EGFR (0.52) EGFR
SCHEMBL21871550 0.78 EGFR (0.60) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017114500-A1 ACRYLANILIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF IN PHARMACY 恩瑞生物医药科技(上海)有限公司 2017-07-06 WO disclosed